Recent breakthroughs in breast cancer treatment for both ER+ and TNBC subtypes have emerged from multidimensional synergistic strategies involving temporal regulation, immune microenvironment remodeling, and metabolic intervention (57). The gene discussed is ESR1; the disease is breast cancer.